NORTRIPTYLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nortriptyline Hydrochloride, and what generic alternatives are available?
Nortriptyline Hydrochloride is a drug marketed by Ani Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Rising, Taro, Teva, Zydus Lifesciences, Pharm Assoc, and Rubicon Research. and is included in eleven NDAs.
The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There is one drug master file entry for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nortriptyline Hydrochloride
A generic version of NORTRIPTYLINE HYDROCHLORIDE was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30th, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORTRIPTYLINE HYDROCHLORIDE?
- What are the global sales for NORTRIPTYLINE HYDROCHLORIDE?
- What is Average Wholesale Price for NORTRIPTYLINE HYDROCHLORIDE?
Summary for NORTRIPTYLINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 25 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 52 |
| Patent Applications: | 1,800 |
| DailyMed Link: | NORTRIPTYLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for NORTRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Irvine | PHASE4 |
| Chang Gung Memorial Hospital | Phase 2 |
| Assiut University | N/A |
Pharmacology for NORTRIPTYLINE HYDROCHLORIDE
| Drug Class | Tricyclic Antidepressant |
